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Abstract
Near IR (NIR) sensitive Au–Au2S nanocolloids were prepared by mixing HAuCl4 and Na2S in aqueous solutions. An anti-tumor drug,
cis-platin, was adsorbed onto Au–Au2S nanoparticle surface via the 11-mercaptoundecanoic acid (MUA) layers. The results show that the
degree of adsorption of cis-platin onto Au–Au2S nanoparticles was controlled by the solution pH value, and the drug release was sensitive to
near-infrared irradiation. The cis-platin-loaded Au–Au2S nanocolloids can be potentially applied as NIR activated drug delivery carrier.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Chemotherapy for the cancer treatment cannot be used to
its full potential because it involves saturating the body with
toxic drugs that produce harmful side effects such as
reduced immune response to infection [1]. Drug delivery
systems (DDS), in which the carriers incorporate the drug
either through chemical bonding or passive adsorption, can
deliver the drug to specific cells or release drugs optimally
at predetermined rates [2,3]. The near-infrared (NIR) radi-
ation, which is nondestructive to human tissues, has been
developed as a DDS approach for cancer therapy [4,5]. In
this approach, the photosensitizing drug is activated when
irradiated by the NIR light during treatment. Moreover,
tissue hyperthermia induced by NIR light, can be synergized
for the release of photosensitizing drug. However, the
traditional NIR photosensors are organic dyes that are
harmful to human tissue, limiting the use of NIR radiation
for cancer therapy.
In this study, NIR sensitive Au–Au2S nanocolloids were
investigated as drug delivery carriers. Zhou et al. [6] and
Averitt et al. [7] reported that NIR sensitivity of Au–Au2S
nanoparticles, where Au2S dielectric core was encapsulated
by a thin gold shell, depended on the particle geometry. Gold
is essentially a bio-inert material with applications ranging
from dental surgery to arthritis treatments [8,9], Au (shell)–
Au2S (core) nanocolloids may also take advantage of the
inherent biocompatibility of gold. Moreover, when using
nanoparticles as drug carriers, the reduction of particle size
to nanoscale not only enables an intravenous injection and
minimizes possible irritant reactions at the injection site [10],
but also allows the carriers to penetrate the membranes of the
diseased cells, and delivers drugs to cancerous tumors [11].
In this paper, we report a preliminary study of the
adsorption of cis-platin, a common drug applied in treatment
of a broad range of solid cancers and lymphomas [12], to
NIR sensitive Au–Au2S nanocolloids. In order to function-
alize the surface of NIR sensitive Au–Au2S nanoparticles,
11-mercaptoundecanoic acid (MUA) was immobilized on
the colloidal carriers before drug adsorption. The chemical
structures of MUA and cis-platin are shown in Fig. 1. MUA
molecules maybe adsorbed onto Au–Au2S nanoparticles
because the thiol (–SH) group is active to gold surface
[13]. Another terminal –COOH group of MUA may provide
further reactivity with cis-platin. The release of cis-platin




Chloroauric acid (HAuCl44H2O) was obtained from
Acros Organics. Sodium sulfide (Na2S9H2O), 11-mercap-
0928-4931/02/$ - see front matter D 2002 Elsevier Science B.V. All rights reserved.
PII: S0928 -4931 (02 )00247 -3
* Corresponding author. Singapore –MIT Alliance, E4-04-10, 4
Engineering Drive 3, National University of Singapore, Singapore
117576, Singapore. Tel.: +65-68761266; fax: +65-67763604/67752920.
E-mail address: smarenl@nus.edu.sg (L. Ren).
www.elsevier.com/locate/msec
Materials Science and Engineering C 23 (2003) 113–116
toundecanoic acid (HS(CH2)10COOH), and cis-platin (cis-
[Pt(NH3)2Cl2]) were obtained from Sigma. All reagents
were used as purchased without further purification. The
glassware were thoroughly cleaned and rinsed with deion-
ized water. Following the literatures [6,7], the growth of
Au–Au2S nanocolloids was initiated when aqueous solu-
tions of HAuCl4 and Na2S were mixed. Briefly, 20 ml of 1
mM Na2S was mixed with 20 ml of 2 mM HAuCl4, and
stored at 25 jC for 1 day. The reaction was monitored using
a UV–visible spectrophotometer at a range of 400–1100
nm. After centrifuging at 15,000 r.p.m., the Au–Au2S
nanoparticles were redispersed in a 100 mM 11-mercap-
toundecanoic acid (MUA) solution in ethanol for 3 days at
40 jC. Excess MUAwere removed from solution by at least
three repeated cycles of centrifuging at 15,000 r.p.m., and
subsequent redispersing in water. Finally, 10 mg of cis-
platin was mixed with 10 ml MUA-modified Au–Au2S
nanocolloids by sonication. Afterwards, the flask containing
the drug carriers was capped and left to stand for 2 days.
Determination of the degree of loading cis-platin onto
nanoparticles was carried out by separating the free cis-
platin molecules from the supernatant fraction after centri-
fuging at 15,000 r.p.m. for 30 min. The concentration of cis-
platin in supernatant was measured by high performance
liquid chromatography (HPLC) method.
2.2. Drug release under NIR light
After centrifuging and rinsing, the cis-platin-loaded Au–
Au2S nanoparticles were transferred to glass vials contain-
ing 2 ml of water. Each vial was then irradiated along its
long axis with a pulsed Nd:YAG laser (1064 nm, 100 mJ/
pulse, 7 ns per pulse length, 10 Hz repetition rate, Surelite
II, Continuum). The entire colloidal solution was exposed to
the cross-sectional area of the beam. During the irradiation
of 1 h, samples were moved from vials at different time
intervals, and the amount of cis-platin released was sub-
sequently determined using HPLC. Control experiments
without laser irradiation were also performed.
2.3. Characterization
Samples for UV–Vis study were placed in quartz crystal
cuvettes (path length 1 cm) and the absorption spectra were
acquired at room temperature using a UV-1601 spectropho-
tometer (Shimadzu). Samples for TEM measurements were
prepared by placing a drop of solution onto carbon-coated
copper grids (200 mesh; 3 mm, Pelco) and left to dry prior
to investigation using a microscope by JEOL 100CX (100
kV accelerating voltage). For Fourier transform infrared
spectroscopy, nanoparticles were recovered from solution
by centrifugation at 15,000 r.p.m. and completely dried by
freeze-drying. The FTIR spectra were obtained by forming
thin (f 100 Am) transparent KBr pellets containing the
materials of interest. The transmission spectra were recorded
by using a Bio-red spectrometer (FTS 135) at a resolution of
4 cm 1, and 256 scans were taken in the range of 400–
4000 cm 1. HPLC measurements were carried out in a
liquid chromatograph instrument with a constant-flow-rate
pump and diode array detector (model HP 1050, Hewlett
Packard, USA). Samples were chromatographed using an
analytical APS-Hypersyl column (Hewlett Packard of 20-
cm length, 4.6-mm internal diameter). The mobile phase had
a flow rate of 1.0 ml/min under isocratic conditions of
acetonitrile–water (90:10). The UV detector was set at 210
nm. Each sample was injected three times and the results
were averaged to obtain the value of the concentration.
3. Results and discussion
Fig. 2 shows a typical TEM bright field image of the cis-
platin-loaded, MUA-modified Au–Au2S nanoparticles. The
drug-loaded spherical particles were about 40–50 nm in
diameter, and a compact core of Au–Au2S nanoparticles
(dark contrast) was surrounded by a coating (light contrast).
The coating presumably consisted of MUA and cis-platin.
Fig. 3 shows the FTIR spectra of Au–Au2S, MUA-modified
Au–Au2S, and cis-platin-loaded Au–Au2S nanoparticles,
respectively. Pure Au–Au2S nanoparticles did not have the
characteristic stretching vibration band of organic groups,
whereas most of the IR bands of MUA were observed for
MUA-modified Au–Au2S nanoparticles. The strongest
bands at 2920 and 1700 cm 1 were assigned to asymmetric
Fig. 1. Chemical structures of cis-platin and MUA.
Fig. 2. TEM image of cis-platin-loaded MUA-modified Au–Au2S
nanoparticles. Core: Au–Au2S; shell: MUA-cisplatin.
L. Ren, G.M. Chow / Materials Science and Engineering C 23 (2003) 113–116114
and symmetric stretching vibrations mCH of the methylene
groups and stretching vibration mCMO of the carboxylic acid
groups of MUA, respectively, indicating that MUA was
adsorbed on the Au–Au2S nanoparticles. The FTIR spectra
for the cis-platin-loaded, MUA-functionalized Au–Au2S
nanoparticles showed the appearance of new bands (indi-
cated by closed circles) at 3280, 3200, 1614, and 1530
cm 1, which were readily identified as the amine group.
This indicates that a substantial amount of cis-platin was
bound to Au–Au2S nanoparticles through the MUA layer. It
is suggested that MUA was adsorbed to Au–Au2S nano-
particles via its –SH end group. The –COOH end group of
MUA may be ionized to –COO group, which may
subsequently provide attachment sites for the protonated
NH3 (NH4
+) group of cis-platin. This resulted in the adsorp-
tion of cis-platin to Au–Au2S nanoparticles via the MUA
layer.
Fig. 4 shows the UV–Vis spectra of Au–Au2S, MUA-
modified Au–Au2S, and cis-platin-loaded, MUA-modified
Au–Au2S nanocolloids. All UV–Vis spectra consisted of
two absorption bands. The band I at 520 nm is assigned to
the surface-plasmon resonance of the Au nanoparticles,
whereas the band II at 790 nm is due to Au-coated Au2S
nanoparticles [6,7]. Fig. 4 also shows that the band II for
both of MUA-modified Au–Au2S and cis-platin-loaded
Au–Au2S nanocolloids shifted to longer wavelength,
which may due to the coating of MUA and cis-platin on
Au–Au2S nanoparticles. Note that Au–Au2S nanocolloids
were stable against aggregation even after 3 months when
coated with MUA at pH 6, whereas the uncoated Au–
Au2S nanocolloids or MUA-coated Au–Au2S nanocolloids
in acidic conditions (pHV 5) aggregated in 1 week (data
not shown). The long-term stability of Au–Au2S nano-
particles against aggregation is important for future appli-
cations.
Fig. 5 shows the effects of solution pH on adsorption
percentage of cis-platin to the MUA-modified Au–Au2S
nanoparticles. The maximum cis-platin adsorption value
(f 80%) was obtained at pH 6.0–7.0. However, below or
above this pH, a smaller amount of cis-platin was absorbed.
At pHV 2.5 orz 8.5, the cis-platin was almost not adsorbed
onto the MUA-modified Au–Au2S nanoparticles. This pH-
dependent behavior can be interpreted as follows: when the
pH was decreased, the COO groups of the MUA layer
became protonated; when the pH was increased, the NH3
group of cis-platin was not protonated to NH4
+. As a result,
ionic bond between COO groups of MUA layer and NH4
+
groups of cis-platin could not readily form in either acidic or
basic solutions.
The release of cis-platin from MUA-modified Au–Au2S
nanoparticles over the observed period (V 1 h) under NIR
Fig. 3. FTIR spectra of Au–Au2S nanoparticles, MUA-modified Au–Au2S
nanoparticles, and cis-platin-loaded, MUA-modified Au–Au2S nano-
particles. .: amine group.
Fig. 4. UV–vis spectra of (a) Au–Au2S nanocolloids, (b) MUA-modified
Au–Au2S nanocolloids, and (c) cis-platin-loaded Au–Au2S nanocolloids.
Fig. 5. Adsorption percentage of cis-platin onto the MUA-modified Au–
Au2S nanoparticles as a function of solution pH.
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light irradiation and by heating (40 jC) without NIR
irradiation is shown in Fig. 6. The NIR irradiation was
performed at room temperature. The temperature of the
solution during irradiation was not monitored. About 90%
of cis-platin was released at the initial period (V 1 min)
under NIR irradiation, and then the rate of release decreased
with increasing time. For heating without NIR irradiation,
the release of cis-platin started after heating at 40 jC for 10
min, and only 40% of cis-platin was released from Au–
Au2S nanoparticles during the period of 1 h. This shows that
more cis-platin was released under NIR irradiation com-
pared to heating without laser irradiation. The control
experiments without laser irradiation or heating showed that
only a little amount (1.2%) of cis-platin was released. It is
thus suggested that the release of cis-platin from Au–Au2S
nanocolloids is sensitive to both of heating and NIR
irradiation. However, such dissociative reaction is more
readily initiated by the absorption of NIR light compared
to heating without laser irradiation. The cis-platin-loaded
Au–Au2S nanocolloids may absorb the NIR photons, and
this absorption with high energy may lead to photochemical
interaction, thermal interaction, photoablation, plasma
induced ablation, and photodisruption among nanocolloids
[14,15]. These interactions may also occur to cause the
cleavage of the ionic bond between COO and NH4
+, and
may finally release cis-platin from Au–Au2S nanoparticles.
However, the mechanism of the interactions between NIR
light and NIR sensitive Au–Au2S nanocolloids is presently
unclear, and detailed work is in progress. The thermal
effects in NIR irradiation also need to be understood. Based
on the results shown in Fig. 5, it is suggested that the
adsorption of cis-platin on Au–Au2S nanoparticles is stable
in physiological conditions where pH is about 7.2–7.4,
however, when NIR light is applied in therapy, cis-platin
will be released from the nanoparticles so that the cancerous
cells will be killed. Hence, our preliminary study of drug
release under NIR irradiation shows that cis-platin-loaded
Au–Au2S nanocolloids can be a potential drug delivery
system for cancer treatment.
4. Summary
We have reported a preliminary study of preparing a drug
carrier system in which MUA was used as a linker between
drug and NIR sensitive Au–Au2S nanoparticles. The degree
of adsorption of cis-platin onto Au–Au2S nanoparticles was
controlled by the solution pH value, and cis-platin was
released from nanoparticles under NIR irradiation at a
greater rate than thermal activation without laser irradiation.
The potential of this drug delivery system for cancer therapy
warrants further investigation.
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Fig. 6. Release of cis-platin from Au–Au2S nanoparticles under Nd:YAG
laser (room temperature) and heating (40 jC, without laser irradiation).
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